MetaCap

Carter Bankshares Quarterly Cash Flow Statement

NASDAQ: CAREFinanceMajor BanksUSD

30.16-0.31 (-1.02%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Carter Bankshares free cash flow

In the quarter ended Jun 30, 2026, Carter Bankshares generated -$260.5 million of operating cash flow and spent $2.3 million on capital expenditures. That left free cash flow of -$262.9 million, a free-cash-flow margin of -382.8% of revenue. Free cash flow was down 3522.2% from the prior year's $7.7 million.

Summary generated from market data by MetaCap's automated system. Methodology

Carter Bankshares cash flow statement (quarterly)

Carter Bankshares quarterly cash flow statement
Quarter (USD)Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31Q3 20232023-09-30
Net Income28.91M85.76M8.48M5.42M8.51M8.95M8.28M5.63M4.80M5.81M-1.89M3.63M
Net Income growth (YoY)+239.73%+857.86%+2.42%-3.73%+77.18%+54.07%—+55.20%-15.80%-63.55%-112.10%-74.83%
Depreciation & Amortization2.15M2.13M2.04M1.97M1.94M1.91M1.84M1.79M1.75M1.67M1.56M1.61M
Stock-Based Compensation616.00K519.00K522.00K539.00K529.00K481.00K428.00K458.00K425.00K441.00K390.00K395.00K
Change in Working Capital7.69M18.71M1.50M1.01M105.00K-3.09M3.34M-131.00K-8.61M8.70M-568.00K1.70M
Operating Cash Flow-260.55M303.92M12.07M11.81M9.60M6.38M11.45M10.31M-2.46M17.63M7.88M9.26M
Capital Expenditures-2.35M-1.54M-3.08M-1.54M-1.92M-1.52M-3.14M-1.88M-1.81M-1.30M-1.82M-2.00M
Investing Cash Flow351.55M-26.62M-11.44M-49.98M-13.44M-81.05M-33.63M-22.83M-22.18M10.24M-51.53M-79.09M
Share Repurchases——-5.96M-4.90M——00000-6.33M
Financing Cash Flow-42.79M-154.14M-2.42M45.20M14.75M32.51M48.35M55.77M-21.72M25.71M42.79M71.95M
Net Change in Cash48.22M123.16M-1.78M7.04M10.91M-42.17M26.18M43.25M-46.36M53.58M-869.00K2.12M
Free Cash Flow-262.89M302.38M9.00M10.28M7.68M4.85M8.31M8.43M-4.27M16.33M6.06M7.26M

This table shows 12 quarterly periods of Carter Bankshares's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CARE's reporting calendar. What is a cash flow statement?

More financial data